MoneyWorks4Me

Fredun Pharmaceuticals informs about board meeting

19 Jun 2018 Evaluate

In compliance to Regulation 33 read with Regulation 30 along with Part A of Schedule 111 of SEBl Listing Regulations, 2015, Fredun Pharmaceuticals has informed that the Board of Directors of the Company, at its Meeting held on Monday, June 18, 2018, have considered and approved the Audited Financials for the year ended March 31, 2018.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..